Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1969 Jul;36(3):623–634. doi: 10.1111/j.1476-5381.1969.tb08017.x

PMN-kinin and kinin metabolizing enzymes in normal and malignant leucocytes

L M Greenbaum, R Freer, J Chang, G Semente, K Yamafuji
PMCID: PMC1703622  PMID: 5305988

Abstract

1. Studies have been carried out on the kinin-forming and kinin destroying activity of rabbit macrophages obtained from the lung before and after BCG injection and from the peritoneal cavity following mineral oil injection. A similar study was carried out with L-1210 leukaemic cells obtained from the peritoneal cavity of mice.

2. The macrophages and leukaemic cells contain enzymes that form kinins from purified kininogen substrates at acid pH. The kinin-forming activity is not limited to the lysosomal fraction of the cell since it is found in extralysosomal compartments. Delta-guanidovaleryl benzyl ester partially inhibits the kinin-forming activity. Trasylol does not inhibit the kinin-forming activity of these cells, but does inhibit the kininases of these cells. The lack of effectiveness of this agent as a general anti-inflammatory agent is thus explained.

3. The kininases of the normal and malignant cells are also inhibited by chloromethyl ketones such as tosyl-lysine chloromethyl ketone (TLCK) and tosyl-phenylalanine-chloromethyl ketone (TPCK) as well as by copper salts. Hydroxyquinoline has no inhibitory action on these cells, indicating that they differ from the plasma kininases.

4. Investigation of the kinins produced by enzymes in rabbit and human polymorphonuclear (PMN) cells has demonstrated the formation of a kinin that differs from bradykinin and other known mammalian kinins in its pharmacological properties, molecular weight, and amino-terminal end group. This peptide has been named PMN-kinin.

5. Overall, the investigation has demonstrated the importance of white cells in contributing to the formation and destruction of “extra-plasma” sources of kinins by enzymes which differ from plasma enzymes. Anti-inflammatory agents may have different actions on these cell enzymes from those on plasma enzymes.

Full text

PDF
623

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COHN Z. A., HIRSCH J. G. The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes. J Exp Med. 1960 Dec 1;112:983–1004. doi: 10.1084/jem.112.6.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. COHN Z. A., WIENER E. THE PARTICULATE HYDROLASES OF MACROPHAGES. I. COMPARATIVE ENZYMOLOGY, ISOLATION, AND PROPERTIES. J Exp Med. 1963 Dec 1;118:991–1008. doi: 10.1084/jem.118.6.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ERDOES E. G., SLOANE E. M., WOHLER I. M. CARBOXYPEPTIDASE IN BLOOD AND OTHER FLUIDS. I. PROPERTIES, DISTRIBUTION, AND PARTIAL PURIFICATION OF THE ENZYME. Biochem Pharmacol. 1964 Jun;13:893–905. doi: 10.1016/0006-2952(64)90033-4. [DOI] [PubMed] [Google Scholar]
  4. Eilam N., Johnson P. K., Johnson N. L., Creger W. P. Bradykininogen levels in Hodgkin's disease. Cancer. 1968 Sep;22(3):631–634. doi: 10.1002/1097-0142(196809)22:3<631::aid-cncr2820220319>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  5. Eisen V., Greenbaum L., Lewis G. P. Kinins and anti-inflammatory steroids. Br J Pharmacol. 1968 Sep;34(1):169–176. doi: 10.1111/j.1476-5381.1968.tb07960.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ferreira S. H., Vane J. R. The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat. Br J Pharmacol Chemother. 1967 Jun;30(2):417–424. doi: 10.1111/j.1476-5381.1967.tb02148.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. GREENBAUM L. M., HOSODA T. Studies on the isolation of bradykininogen. Biochem Pharmacol. 1963 Apr;12:325–330. doi: 10.1016/0006-2952(63)90057-1. [DOI] [PubMed] [Google Scholar]
  8. GREENBAUM L. M., YAMAFUJI K., HOSODA T. STUDIES OF THE PEPTIC DEGRADATION OF BOVINE BRADYKININOGEN. Biochem Pharmacol. 1965 Apr;14:411–420. doi: 10.1016/0006-2952(65)90214-5. [DOI] [PubMed] [Google Scholar]
  9. Greenbaum L. M., Carrara M. C., Freer R. Inflammatory response and bradykinin. Fed Proc. 1968 Jan-Feb;27(1):90–91. [PubMed] [Google Scholar]
  10. Greenbaum L. M., Kim K. S. The kinin-forming and kininase activities of rabbit polymorphonuclear leucocytes. Br J Pharmacol Chemother. 1967 Feb;29(2):238–247. doi: 10.1111/j.1476-5381.1967.tb01956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Greenbaum L. M., Yamafuji K. The in vitro inactivation and formation of plasma kinins by spleen cathepsins. Br J Pharmacol Chemother. 1966 May;27(1):230–238. doi: 10.1111/j.1476-5381.1966.tb01658.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HIRSCHBERG E., BRINDLE S. D., SEMENTE G. DEVELOPMENT AND PROPERTIES OF MOUSE LEUKEMIA L1210 RESISTANT TO MIRACIL D. Cancer Res. 1964 Nov;24:1733–1737. [PubMed] [Google Scholar]
  13. MYRVIK Q. N., LEAKE E. S., OSHIMA S. A study of macrophages and epitheloid-like cells from granulomatous (BCG-induced) lungs of rabbits. J Immunol. 1962 Nov;89:745–751. [PubMed] [Google Scholar]
  14. MYRVIK Q., LEAKE E. S., FARISS B. Studies on pulmonary alveolar macrophages from the normal rabbit: a technique to procure them in a high state of purity. J Immunol. 1961 Feb;86:128–132. [PubMed] [Google Scholar]
  15. Muramatu M., Fujii S. Inhibitory effects of omega-guanidino acid esters on trypsin, plasmin, thrombin and plasma kallikrein. J Biochem. 1968 Dec;64(6):807–814. doi: 10.1093/oxfordjournals.jbchem.a128963. [DOI] [PubMed] [Google Scholar]
  16. Pisano J. J. Vasoactive peptides in venoms. Fed Proc. 1968 Jan-Feb;27(1):58–62. [PubMed] [Google Scholar]
  17. SCHOELLMANN G., SHAW E. Direct evidence for the presence of histidine in the active center of chymotrypsin. Biochemistry. 1963 Mar-Apr;2:252–255. doi: 10.1021/bi00902a008. [DOI] [PubMed] [Google Scholar]
  18. Yang H. Y., Erdös E. G. Second kininase in human blood plasma. Nature. 1967 Sep 23;215(5108):1402–1403. doi: 10.1038/2151402a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES